Recruiting Duchenne Muscular Dystrophy Studies in Palo Alto
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)...
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RGX-202 is a gene therapy designed to deliver a transgene for a novel microdystrophin that includes functional elements of naturally-occurring dystrophin including the C-Terminal (CT) domain. This is...
About Duchenne Muscular Dystrophy Clinical Trials in Palo Alto
Duchenne muscular dystrophy is a severe genetic disorder characterized by progressive muscle degeneration and weakness, primarily affecting boys. It is caused by mutations in the dystrophin gene. Treatment includes corticosteroids, gene therapies, and supportive care to maintain mobility and function.
There are currently 2 duchenne muscular dystrophy clinical trials recruiting participants in Palo Alto, CALIFORNIA. These studies are seeking a combined 265 participants. Research is being sponsored by Avidity Biosciences, Inc., REGENXBIO Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Duchenne Muscular Dystrophy Clinical Trials in Palo Alto — FAQ
Are there duchenne muscular dystrophy clinical trials in Palo Alto?
Yes, there are 2 duchenne muscular dystrophy clinical trials currently recruiting in Palo Alto, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Palo Alto?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.
Are clinical trials in Palo Alto free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.
What duchenne muscular dystrophy treatments are being tested?
The 2 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for duchenne muscular dystrophy.
Data updated March 2, 2026 from ClinicalTrials.gov